Table 4 Evaluation of injection site reactions (safety population).

From: Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

  

Risperidone ISM

Risperidone ISM

Time point

Placebo

75 mg

100 mg

Statistic

N = 147

N = 144

N = 146

Any reaction, n (%)

9 (6.1)

12 (8.3)

14 (9.6)

Redness, n (%)

7 (4.8)

9 (6.3)

11 (7.5)

Swelling, n (%)

3 (2.0)

3 (2.1)

2 (1.4)

Induration, n (%)

0 (0)

2 (1.4)

1 (0.7)

Back to article page